Streetbeat News

Analyst Ratings

TRVN

Trevena Inc (NASDAQ:TRVN) released preliminary topline data from two Phase 1 proof-of-concept studies of TRV045, demonstrating CNS penetration and target engagement. The studies showed a statistically significant, dose-dependent reduction in mechanical allodynia. No serious adverse events were reported. Full safety and tolerability data is expected in early 4Q 2023. Concurrently, Trevena received a $15 million tranche under its non-dilutive ex-US royalty-based financing, triggered by the first commercial sale of Olinvyk in China. TRVN shares are up 23.4% at $1.08 during the premarket session.

Portfolio Pulse from Vandana Singh

September 06, 2023 | 1:23 pm

APDN

Applied DNA Sciences, Inc. (NASDAQ:APDN) has appointed Beverly Wolgast as executive director of Quality and cGMP Programs. Wolgast will oversee quality assurance, control, and regulatory compliance across the company's three business segments. She brings over 30 years of experience in the pharmaceutical and biotech industry, including her recent role as Director of CleanCap GMP Manufacturing at TriLink BioTechnologies, a division of Maravai LifeSciences, where she led the manufacture of the BioNTech/Pfizer COVID-19 vaccine.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 1:20 pm

LNG

Capital One has initiated coverage on Cheniere Energy (AMEX:LNG) with an Overweight rating and a price target of $200.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 1:14 pm

ARKK

DOGE-USD

GOOGL

TSLA

Crypto analyst predicts a 170% upside for Dogecoin by 2024. Google accidentally leaks a 360-degree view of the upcoming Pixel 8 Pro. Cathie Wood's Ark Invest continues to sell Shopify and Nvidia shares, while buying Spotify stock. Coinbase-incubated Base faces a major outage but assures no funds are at risk. Tesla, GM, Ford are among automakers targeted by NHTSA over faulty airbag inflators. Tesla raises the price of its Yoke steering wheel amidst recent Model S, X price adjustments.

Portfolio Pulse from Akanksha Bakshi

September 06, 2023 | 1:13 pm

TVTX

Evercore ISI Group analyst Liisa Bayko has reinstated Travere Therapeutics (NASDAQ:TVTX) with an Outperform rating and announced a $30 price target.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 1:13 pm

KVUE

Argus Research analyst Taylor Conrad has initiated coverage on Kenvue (NYSE:KVUE) with a Hold rating.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 1:11 pm

PETQ

Lake Street analyst Ryan Meyers has initiated coverage on PetIQ (NASDAQ:PETQ) with a Buy rating and a price target of $28.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 1:10 pm

CRGO

Oppenheimer analyst Jason Helfstein has initiated coverage on Freightos (NASDAQ:CRGO) with an Outperform rating and a price target of $5.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 1:08 pm

ALLE

Longbow Research analyst David Macgregor has downgraded Allegion (NYSE:ALLE) from Buy to Neutral.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 1:06 pm

MP

Northland Capital Markets analyst Abhishek Sinha has upgraded MP Materials (NYSE:MP) from Market Perform to Outperform.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 1:05 pm